Pfizer
PFE
2,952 hedge funds and large institutions have $106B invested in Pfizer in 2026 Q1 according to their latest regulatory filings, with 256 funds opening new positions, 1,303 increasing their positions, 1,088 reducing their positions, and 167 closing their positions.
53% more first-time investments, than exits
New positions opened: 256 | Existing positions closed: 167
52% more funds holding in top 10
Funds holding in top 10: 31 → 47 (+16)
20% more repeat investments, than reductions
Existing positions increased: 1,303 | Existing positions reduced: 1,088
15% more call options, than puts
Call options by funds: $3.08B | Put options by funds: $2.68B
14% more capital invested
Capital invested by funds: $93B → $106B (+$12.6B)
1% more funds holding
Funds holding: 2,913 → 2,952 (+39)
0.46% more ownership
Funds ownership: 65.68% → 66.15% (+0.46%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$1.41B |
| 2 |
D.E. Shaw & Co
New York
|
+$241M |
| 3 |
Goldman Sachs
New York
|
+$188M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$176M |
| 5 |
Bank of New York Mellon
New York
|
+$143M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$176M |
| 2 |
Amundi
Paris,
France
|
-$166M |
| 3 |
Janus Henderson Group
London,
|
-$148M |
| 4 |
Corient Private Wealth
Miami,
Florida
|
-$145M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$114M |
PFE Hedge Fund Activity: Q1 2026 in Review
2,952 of the 8,172 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q1 2026, worth a combined $106B — up 14% from $93B a quarter earlier.
Buyers outnumbered sellers: 256 funds opened new PFE positions and 167 closed out — a net gain of 89 holders — while 1,303 added to existing stakes and 1,088 trimmed.
The largest buyer was Fisher Asset Management, adding an estimated $1.41B. The largest seller was BNP Paribas Financial Markets, cutting an estimated $176M.
- 2,952 institutional investors held Pfizer (PFE) as of Q1 2026, up from 2,913 in Q4 2025.
- Funds reported $106B of Pfizer stock for Q1 2026, up 14% quarter-over-quarter.
- 256 funds opened new Pfizer positions in Q1 2026 and 167 closed out, a net change of +89 holders.
- The largest Pfizer buyer in Q1 2026 was Fisher Asset Management, an estimated $1.41B added.
- The largest Pfizer seller in Q1 2026 was BNP Paribas Financial Markets, an estimated $176M sold.
Based on aggregated 13F filings for Q1 2026.